ABSTRACT Cloned probes of herpes simplex virus type 2 DNA were used in cytological hybridization experiments to detect herpesvirus RNA transcripts in the neoplastic cells of tumors of the uterine cervix. Virus-specific RNA was shown to represent transcription of limited regions of the genome, of which one is known to code for a DNA-binding protein that can be found by immunoperoxidase staining in the neoplastic cells of these tumors and has also been detected in cells transformed in vitro by this virus.
The thesis that the continuum of disease leading to the development of uterine cervical carcinoma is associated with prior infection by herpes simplex virus type 2 (HSV-2) (1) (2) (3) (4) (5) has recently been tested at the molecular level by the use of in situ cytological hybridization (6) (7) (8) (9) . The use of 3H-labeled viral DNAs as probes to detect virus-specific RNA (10, 11) in cervical tissue has resulted in general agreement, based on published reports, that at least 30% ofall cervical intraepithelial neoplasia (CIN) and cervical carcinoma tissues contain cells that bind a HSV-2 [3H]DNA probe but not probes representing other viral DNAs, indicating the presence of HSV-specific RNA (7) (8) (9) . The majority of these in situ hybridizations have been conducted with whole genomic DNA as the probe. In this report we summarize our studies using cloned subgenomic fragments of HSV-2 DNA as hybridization probes to define regions of the virus genome from which the detected RNA species are transcribed and correlate the findings with attempts to identify viral antigen(s) expressed in cervical carcinoma cells.
There have been numerous reports that antibodies to HSVspecific proteins are found more frequently, or at higher titer, in women with CIN or cervical carcinoma than in controls (12) (13) (14) and that HSV-specific antigens can be detected in the neoplastic cells by immunofluorescent or other methods (15) (16) (17) . Among the abundance ofsometimes confusing data (18, 19) , two series of recent reports were of interest with respect to our in situ hybridization results. First, antiserum to the major HSV-2 binding protein (20) was shown to react with human cervical carcinoma cells in two separate studies (21, 22) . The tumor antigens of other DNA viruses have been shown, without exception, to have DNA-binding properties (23) , and a herpes simplex tumor antigen might be expected to exhibit a similar function. Second, it was demonstrated that sera from patients with cervical carcinoma precipitated two HSV-2 polypeptides (with molecular weights 38,000 and 118,000) more frequently than did sera from controls (24) .
The 38,000-dalton protein was ofinterest because it has been shown that a protein of this size is encoded within Bgl II fragment N of HSV-2 DNA (25, 26) , which has been reported to have transforming activity in rodent cells (27, 28) .
Rodent cells transformed in vitro by HSV-2 have been reported to express a number of HSV-specific antigens including VP143 (29) , ICP10 (30), thymidine kinase (31, 32) , membrane glycoproteins gA/gB (33, 34) , and CP-1 (35) . We therefore examined the HSV-2 transformants available in this laboratory in parallel with specimens of cervical carcinoma in an attempt to find a protein universally present in cells transformed in vitro and possibly in vivo by HSV-2.
MATERIALS AND METHODS Cells and Viruses. The properties of the transformed cells used in this study have been described (11, 28, 36) . Cells were cultured in an atmosphere of 10% C02/90% air in Dulbecco's modification of Eagle's medium (Bio-Rad) with 10% fetal calf serum (Reheis, Kankakee, IL) on plastic tissue culture plates (Falcon). HSV-2 strain 333 was propagated on monolayers of BHK-21 cells infected at low multiplicity (0.01 plaque-forming unit per cell). Viral DNA was isolated by equilibrium gradient centrifugation through sodium iodide gradients containing ethidium bromide (37) .
Human Uterine Cervical Tissues. Human cervical tissue was obtained during colposcopic examination from patients who had been referred for the evaluation of abnormal Papanicolaou smears. Biopsy specimens were taken from those areas most likely to contain cervical cancer precursors as identified by colposcopy. The specimens were frozen in a cryostat, the diagnosis was confirmed by examination of frozen sections, and permanent diagnostic sections were prepared. The tissue remaining after the diagnostic evaluation was stored at -70'C until further sections were prepared. Benign cervical tissue from normalappearing cervical transformation zones was also obtained from hysterectomy specimens of patients whose uteri were removed for other reasons. These were snap-frozen and stored at -70'C.
The cervical tissues were divided into three categories: (i) benign (including squamous metaplasia), (ii) CIN (dysplasia and carcinoma in situ), and (iii) invasive cancer. The tissues obtained that did not include the transformation zone were also subjected to the hybridization studies despite the fact that cervical squamous cell neoplasia generally does not arise in this region. The biopsies were interpreted as benign ifthe squamous epithelium matured in a normal fashion or if they contained the immature cells of squamous metaplasia at the surface or in the endocervical glands. The CIN lesions were classified by using the criteria advocated by Richart (38) Hybridization. The construction and characterization of the recombinant clones of HSV-2 DNA in plasmid pBR322 have been described (39) . The introduction of 3H-labeled nucleotides into cloned DNA for use as hybridization probes was carried out as described (40) .
Frozen-sectioned biopsy tissues placed on glass slides were fixed and stored in ethanol at -20°C until required for hybridization. After the preparations were dried in vacuum desiccators to remove all traces of ethanol, 10 A.l of probe was applied to each, and the drop-was covered with a washed, silicone-treated coverslip. Hybridization was carried out in 6 X standard saline citrate (NaCi/Cit; lx NaCi/Cit = 0.15 M NaCV0.015 M sodium citrate) at 680C for 18 hr. After this period, the coverslips were removed and the slides were washed extensively in large volumes of 2x NaCl/Cit at 40C. Following dehydration in ethanol and under reduced pressure, the slides were dipped in Kodak NTB2 emulsion, diluted 1:1 with distilled water containing 1% glycerol, dried, and stored in light-tight boxes at 40C for autoradiography. Preparations were developed in Kodak D19 and fixed in Kodafix. Cells and tissues were stained in 10% Giemsa, and the stained sections were examined for evidence of silver grains. Cells with 10 or more grains were considered positive when the background level was 1-3 grains per cell.
Antibodies and Immunoprecipitation. Hybridoma cell lines producing monoclonal antibodies were isolated by the method of Kohler and Milstein (41) . Spleen cells from C57BL/6 mice infected with HSV-2 (333) were fused with BALB/c NSI myeloma cells by procedures described in detail elsewhere (41) . Culture supernatants were assayed for anti-HSV antibodies by an antibody-binding assay (42) utilizing "2I-labeled protein A against HSV-2-infected cell antigens. Three HSV-2-specific monoclonal antibodies were used in this study: one, antibody 6-A6, primarily precipitated a 140,000-dalton protein together with less preference for a 38,000-dalton protein; conversely, antibody 6-Hll primarily reacted with a 38,000-dalton protein and less so with a 140,000-dalton protein (26) . Antiserum (monospecific) to ICSP 11/12 was kindly provided by K. L. Powell (University of Leeds, England); anti-VP143 was provided by R. J. Courtney (University of Tennessee).
Immunoprecipitation reaction mixtures consisted of 100 ,ul (44) . The precipitated proteins and antibodies were solubilized in 0.05 M Tris HCl, pH 7.0/2% (wt/vol) NaDodSO4/5% 2-mercaptoethanoV0.055% bromophenol blue at 100'C for 2 min for analysis by electrophoresis in NaDodSOd9% polyacrylamide slab gels. Autoradiography was enhanced by fluorography using the commercial reagent EN3HANCE (New England Nuclear).
Immunofluorescence and Immunoperoxidase Staining. The methods used were as described (45) . RESULTS HSV-Specific RNA in Cervical Tissues. Cloned and restriction endonuclease-derived fragments of HSV-2 DNA were hybridized to 75 frozen-sectioned biopsy specimens of neoplastic cervical tissue and carcinoma (Fig. 1) . Another 50 samples of non-neoplastic cervical squamous epithelium and frozen sections from other tissues were hybridized with the HSV-2 probes as controls. Heterologous virus probes (simian virus 40, adenovirus 2, and bacteriophage A) were hybridized to replicate sections to control for nonspecific binding of nick-translated DNA (7, 9) . The results of the hybridizations with the HSV-2 probes only are shown in Table 1 
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Because these heterologous probes were never bound to specimens negative for HSV, our interpretation is that, in those specimens binding multiple heterologous probes, the result indicates a nonspecific interaction. This occurred in approximately 10% ofthe tissues examined. The distribution ofpositive hybridization results with HSV-2 DNA probes shows that the RNA species detected are limited to three regions of the virus genome: positions 0.07 to 0.4, 0.58 to 0.63, and 0.82 to 0.85 (Fig. 2) . This last region is in the short repeat sequences and is therefore also represented at position 0.94 to 0.96 (46) .
Herpesvirus-Specific Antigens. Transformed cells and cervical biopsy specimens were tested by immunofluorescence and immunoperoxidase methods for the presence ofherpesvirus antigens. None of the three HSV-2-specific monoclonal antisera (A6, Hil, and E12) gave positive staining reactions on transformed cells or with cervical tissues although they reacted with HSV-2-infected cells ( Table 2 ). The monospecific antiserum ICSP 11/12 and antiserum VP143 were positive on virus-infected and transformed cells and on the neoplastic cells in some ofthe CIN and cervical carcinoma sections ( Fig. 3 ; Table 2 ). The results found with the anti-VP143 and ICSP 11/12 antisera closely parallel the in situ hybridization results. When benign cervical tissue was examined, HSV antigens were occasionally seen in isolated mature squamous epithelial cells near the surface in the portio or transformation zone in a pattern suggesting an acute infection. In immature squamous metaplastic cells of the transformation zone, or in basal cell hyperplasia, the cells that were positive were in a basal location rather than a superficial one. Approximately 30% of the sections classified as CIN I, II, or III had detectable antigen, which was limited to the neoplastic cells, similar to the result found in vulvar intraepithelial neoplasia (Fig. 4) , and approximately 20% ofthe invasive (29) . The Bgl II region N of HSV-2 also persists in these cells (36) but no evidence ofthe 38,000-dalton protein encoded by the Bgl II region N sequences was found in this study. Other experiments (26) have shown that monoclonal antibodies A6 and Hil react with two proteins translated in vitro from RNA selected with Bgl II fragment N of HSV-2. The coding sequences for these proteins have been shown to be partially co-linear and, for the larger protein, to be also encoded in part within Bgl II fragment C. Cells transformed in vitro with Bgl II N sequences alone do not appear to express the 38,000-dalton protein. It is possible that Bgl II region N products are present in amounts too low to be detected or that they may only be required for initiation. It is interesting that, even though cervical carcinoma cells are negative for this protein, it has been shown (24) that cervical cancer patients may have significantly increased levels of antibody to the 38,000-dalton protein.
Except for one report (52) , attempts to detect HSV DNA in cervical carcinoma tissues have failed (53, 54) . The demonstration that viral RNA and protein are present in about 30% ofthese cases has stimulated us to investigate more tumors at the DNA level by hybridization with the cloned DNA probes containing transforming sequences from HSV-1 and HSV-2. These segments of DNA provide greater sensitivity than was available for the earlier studies (55) . Cloning of DNA from tumor tissues to provide libraries that can be screened (56) for herpesvirus sequences will also enable more sensitive detection ofviral DNA.
